These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9328951)

  • 41. Carpal tunnel syndrome and type of dialysis membrane used in patients undergoing long-term hemodialysis.
    Chanard J; Lavaud S; Toupance O; Roujouleh H; Melin JP
    Arthritis Rheum; 1986 Sep; 29(9):1170-1. PubMed ID: 3530257
    [No Abstract]   [Full Text] [Related]  

  • 42. Using ultrapure water in hemodialysis delays carpal tunnel syndrome.
    Baz M; Durand C; Ragon A; Jaber K; Andrieu D; Merzouk T; Purgus R; Olmer M; Reynier JP; Berland Y
    Int J Artif Organs; 1991 Nov; 14(11):681-5. PubMed ID: 1757154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood lead level: an overlooked risk of carpal tunnel syndrome in hemodialysis patients.
    Huang WH; Hu CC; Yen TH; Hsu CW; Weng CH
    Ren Fail; 2019 Nov; 41(1):786-793. PubMed ID: 31498017
    [No Abstract]   [Full Text] [Related]  

  • 44. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
    Haufe CC; Eismann U; Deppisch RM; Stein G
    Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients.
    Gejyo F; Homma N; Arakawa M
    Blood Purif; 1988; 6(2):125-31. PubMed ID: 3293616
    [No Abstract]   [Full Text] [Related]  

  • 47. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating form of beta-2-microglobulin in dialysis patients.
    Gagnon RF; Somerville P; Thomson DM
    Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
    Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
    Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Amyloid deposits in hemodialysis patients: immunochemical analysis].
    Argiles A; Mourad G; Axelrud-Cavadore C; Cavadore JC; Mion C
    Nephrologie; 1987; 8(2):51-4. PubMed ID: 3302740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
    Gejyo F; Homma N; Arakawa M
    Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study.
    Jadoul M; Garbar C; Noël H; Sennesael J; Vanholder R; Bernaert P; Rorive G; Hanique G; van Ypersele de Strihou C
    Kidney Int; 1997 Jun; 51(6):1928-32. PubMed ID: 9186884
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dialyzer Reuse and Outcomes of High Flux Dialysis.
    Argyropoulos C; Roumelioti ME; Sattar A; Kellum JA; Weissfeld L; Unruh ML
    PLoS One; 2015; 10(6):e0129575. PubMed ID: 26057383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.
    Gejyo F; Odani S; Yamada T; Honma N; Saito H; Suzuki Y; Nakagawa Y; Kobayashi H; Maruyama Y; Hirasawa Y
    Kidney Int; 1986 Sep; 30(3):385-90. PubMed ID: 3537446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significance of the decreased risk of dialysis-related amyloidosis now proven by results from Japanese nationwide surveys in 1998 and 2010.
    Hoshino J; Yamagata K; Nishi S; Nakai S; Masakane I; Iseki K; Tsubakihara Y
    Nephrol Dial Transplant; 2016 Apr; 31(4):595-602. PubMed ID: 26206763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis.
    Gejyo F; Homma N; Suzuki Y; Arakawa M
    N Engl J Med; 1986 Feb; 314(9):585-6. PubMed ID: 3080684
    [No Abstract]   [Full Text] [Related]  

  • 57. Beta 2-microglobulin amyloidosis (AB2M) in patients undergoing long-term hemodialysis. A new type of amyloid.
    Fuchs A; Jagirdar J; Schwartz IS
    Am J Clin Pathol; 1987 Sep; 88(3):302-7. PubMed ID: 3307375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasonographic evaluation of the carpal tunnel syndrome in hemodialysis patients.
    Ikegaya N; Hishida A; Sawada K; Furuhashi M; Maruyama Y; Kumagai H; Kobayashi S; Yamamoto T; Yamazaki K
    Clin Nephrol; 1995 Oct; 44(4):231-7. PubMed ID: 8575122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study.
    Port FK; Wolfe RA; Hulbert-Shearon TE; Daugirdas JT; Agodoa LY; Jones C; Orzol SM; Held PJ
    Am J Kidney Dis; 2001 Feb; 37(2):276-86. PubMed ID: 11157367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting beta 2-microglobulin plasma concentration during hemodialysis.
    Martin-Malo A; Mallol J; Castillo D; Barrio V; Burdiel LG; Perez R; Aljama P
    Int J Artif Organs; 1989 Aug; 12(8):509-14. PubMed ID: 2681000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.